The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Preliminary routes focused on amino acid chain portion coupling, utilizing https://zaynabzqez576117.thezenweb.com/production-and-study-implementations-of-retatrutide-79373742